Holly A Anger1, Jill Durocher1, Rasha Dabash1, Nevine Hassanein2, Sam Ononge3, Gillian Burkhardt1,4, Laura J Frye1, Ayisha Diop1, Seynabou Bop Moctar Beye Diop5, Emad Darwish6, Mohamed Cherine Ramadan7, Juliana Kayaga8, Dyanna Charles1, Alioune Gaye9, Melody Eckardt10, Beverly Winikoff1. 1. Gynuity Health Projects, New York, New York, United States of America. 2. Obstetrician/Gynecologist Consultant, Alexandria, Egypt. 3. Makerere University School of Health Sciences, Kampala, Uganda. 4. Department of Obstetrics and Gynecology, University of New Mexico, Albuquerque, New Mexico, United States of America. 5. Centre De Santé Philippe Senghor, Dakar, Senegal. 6. Alexandria Faculty of Medicine, Alexandria University, Alexandria, Egypt. 7. El Galaa Maternity Teaching Hospital, Cairo, Egypt. 8. Global Health Uganda, Kampala, Uganda. 9. Obstetrician/Gynecologist Consultant, Dakar, Senegal. 10. Global Health Innovation Lab, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Abstract
OBJECTIVE: We aimed to determine the risk of postpartum infection and increased pain associated with use of condom-catheter uterine balloon tamponade (UBT) among women diagnosed with postpartum hemorrhage (PPH) in three low- and middle-income countries (LMICs). We also sought women's opinions on their overall experience of PPH care. METHODS: This prospective cohort study compared women diagnosed with PPH who received and did not receiveUBT (UBT group and no-UBTgroup, respectively) at 18 secondary level hospitals in Uganda, Egypt, and Senegal that participated in a stepped wedge, cluster-randomized trial assessing UBT introduction. Key outcomes were reported pain (on a scale 0-10) in the immediate postpartum period and receipt of antibiotics within four weeks postpartum (a proxy for postpartum infection). Outcomes related to satisfaction with care and aspects women liked most and least about PPH care were also reported. RESULTS: Among women diagnosed with PPH, 58 were in the UBT group and 2188 in the no-UBT group. Self-reported, post-discharge antibiotic use within four weeks postpartum was similar in the UBT (3/58, 5.6%) and no-UBT groups (100/2188, 4.6%, risk ratio = 1.22, 95% confidence interval [CI]: 0.45-3.35). A high postpartum pain score of 8-10 was more common among women in the UBT group (17/46, 37.0%) than in the no-UBT group (360/1805, 19.9%, relative risk ratio = 3.64, 95% CI:1.30-10.16). Most women were satisfied with their care (1935/2325, 83.2%). When asked what they liked least about care, the most common responses were that medications (580/1511, 38.4%) and medical supplies (503/1511, 33.3%) were unavailable. CONCLUSION:UBT did not increase the risk of postpartum infection among this population. Women who receive UBT may experience higher degrees of pain compared to women who do not receive UBT. Women's satisfaction with their care and stockouts of medications and other supplies deserve greater attention when introducing new technologies like UBT.
RCT Entities:
OBJECTIVE: We aimed to determine the risk of postpartum infection and increased pain associated with use of condom-catheter uterine balloon tamponade (UBT) among women diagnosed with postpartum hemorrhage (PPH) in three low- and middle-income countries (LMICs). We also sought women's opinions on their overall experience of PPH care. METHODS: This prospective cohort study compared women diagnosed with PPH who received and did not receive UBT (UBT group and no-UBT group, respectively) at 18 secondary level hospitals in Uganda, Egypt, and Senegal that participated in a stepped wedge, cluster-randomized trial assessing UBT introduction. Key outcomes were reported pain (on a scale 0-10) in the immediate postpartum period and receipt of antibiotics within four weeks postpartum (a proxy for postpartum infection). Outcomes related to satisfaction with care and aspects women liked most and least about PPH care were also reported. RESULTS: Among women diagnosed with PPH, 58 were in the UBT group and 2188 in the no-UBT group. Self-reported, post-discharge antibiotic use within four weeks postpartum was similar in the UBT (3/58, 5.6%) and no-UBT groups (100/2188, 4.6%, risk ratio = 1.22, 95% confidence interval [CI]: 0.45-3.35). A high postpartum pain score of 8-10 was more common among women in the UBT group (17/46, 37.0%) than in the no-UBT group (360/1805, 19.9%, relative risk ratio = 3.64, 95% CI:1.30-10.16). Most women were satisfied with their care (1935/2325, 83.2%). When asked what they liked least about care, the most common responses were that medications (580/1511, 38.4%) and medical supplies (503/1511, 33.3%) were unavailable. CONCLUSION: UBT did not increase the risk of postpartum infection among this population. Women who receive UBT may experience higher degrees of pain compared to women who do not receive UBT. Women's satisfaction with their care and stockouts of medications and other supplies deserve greater attention when introducing new technologies like UBT.
Authors: Meghan A Bohren; Joshua P Vogel; Erin C Hunter; Olha Lutsiv; Suprita K Makh; João Paulo Souza; Carolina Aguiar; Fernando Saraiva Coneglian; Alex Luíz Araújo Diniz; Özge Tunçalp; Dena Javadi; Olufemi T Oladapo; Rajat Khosla; Michelle J Hindin; A Metin Gülmezoglu Journal: PLoS Med Date: 2015-06-30 Impact factor: 11.069
Authors: Joseph Ngonzi; Lisa M Bebell; Yarine Fajardo; Adeline A Boatin; Mark J Siedner; Ingrid V Bassett; Yves Jacquemyn; Jean-Pierre Van Geertruyden; Jerome Kabakyenga; Blair J Wylie; David R Bangsberg; Laura E Riley Journal: BMC Pregnancy Childbirth Date: 2018-06-28 Impact factor: 3.007
Authors: Alexandre Dumont; Cécile Bodin; Benjamin Hounkpatin; Thomas Popowski; Mamadou Traoré; René Perrin; Patrick Rozenberg Journal: BMJ Open Date: 2017-09-01 Impact factor: 2.692